Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection
Двухкомпонентная наночастичная вакцина на основе спайкового белка защищает макак от инфекции SARS-CoV-2
2020-01-01
SCID: 54.1/vrjhuxwm
Discuss with AI
SARS-CoV-2 spike proteincynomolgus macaquesneutralizing antibody responsesprotein-based nanoparticle vaccineviral infection and replication
Figures from the paper
Abstract (AI)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease. Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein. Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques. The vaccine-induced immunity protects macaques against a high-dose challenge, resulting in strongly reduced viral infection and replication in the upper and lower airways. These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.
Key Findings
1
A two-component protein-based nanoparticle vaccine displays multiple copies of the SARS-CoV-2 spike protein.
2
The nanoparticle vaccine is identified as a promising candidate for limiting SARS-CoV-2 transmission and disease.
3
The vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques.
4
Vaccination protects cynomolgus macaques against high-dose SARS-CoV-2 challenge.
5
Vaccine-induced immunity strongly reduces viral infection and replication in both upper and lower airways of macaques.
Research Object
The two-component protein-based nanoparticle vaccine displaying multiple copies of the SARS-CoV-2 spike protein
Research Subject
Its immunogenicity and protective efficacy against SARS-CoV-2 infection and replication in the airways of cynomolgus macaques
Publication Details
Publication Date
2020-01-01
Journal
Publisher
ISSN
Cited by
193
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-22020
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping2020
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates2021